IZREVLU

What this means for you

This application is over — abandoned 14 Sept 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

79440401

Mark type

Word mark

Filed

12 Nov 2025

Abandoned

14 Sept 2026

Attorney of record

Maury M. Tepper, III

Goods and services

• Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Owner

• Novartis AG, CH

Prosecution history

• 28 Sept 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 28 Sept 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 25 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
• 25 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 25 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 25 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 25 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 26 Mar 2026 — REFUSAL PROCESSED BY IB
• 12 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 12 Mar 2026 — REFUSAL PROCESSED BY MPU
• 07 Feb 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 06 Feb 2026 — NON-FINAL ACTION WRITTEN
• 30 Jan 2026 — ASSIGNED TO EXAMINER
• 29 Jan 2026 — APPLICATION FILING RECEIPT MAILED
• 29 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED